2-Cyano-4-methoxyphenylboronic Acid, 95.0%, 100mg

16-Bromohexadecanoic acid, 95.0%, 1g

5-(3,5-Di-tert-butyl-4-hydroxybenzyl)thiazolidin-4-one, 98%, 10mg

2-Butanol, min. 98.5%, for synthesis, 5 l, plastic packaging.

(2-(Difluoromethoxy)-5-fluorophenyl)boronic acid, 95+%, 1g

tert-Butyl 6-chloro-2-iodo-1H-pyrrolo[3,2-c]pyridine-1-carboxylate, 97%, 1g

4-(3-Aminophenyl)butanoic acid hydrochloride, 95.0%, 1g

2-Aminopyrimidine-5-carbaldehyde, 95.0%, 10g

2-(5,6,7,8-tetrahydro-2-naphthalenyloxy)butanoic acid, 95.0%, 1g

Propanamide, N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinyl]-2-oxoethyl]-2-(methylamino)-, (2S)-, 99%, 50mg

5-Fluoro-6-methoxynicotinic acid, 95.0%, 1g

DIHYDRORESVERATROL, 95%, 250mg

(3-Amino-2-fluorophenyl)boronic acid pinacol ester, 95.0%, 10g